Pro Generika e.V. becomes shareholder of the industry’s database system in the securPharm-system
Pro Generika e.V. becomes shareholder of the industry’s database system in the securPharm-system – a further step towards the implementation of the EU-Falsified Medicines Directive in Germany
Yesterday Pro Generika e.V. joined ACS PharmaProtect GmbH (ACS) as fourth shareholder. ACS develops and operates the database system of the industry in Germany and was founded for this purpose in 2012 from the Bundesverband der Arzneimittelhersteller e.V. (BAH), the Bundesverband der Pharmazeutischen Industrie e.V. (BPI) and the Verband Forschender Arzneimittelhersteller e.V. (vfa). The system is an important part of securPharm.
“This step shows, that the entire German pharmaceutical industry pushes the prevention of the entry of falsified medicines into the legal supply chain", says Dr. Wolfgang Stock, managing director of ACS PharmaProtect GmbH. "We are pleased, that with this step an important milestone for the setup of the system was achieved, and an entire sector jointly works together."
To prevent falsified medicines from entering the legal supply chain it is required by law that starting from Februar 2019, that medicines must be checked of their authenticity prior the dispense to patients. The therefore required data have to be stored by the pharmaceutical companies in the database system which is provided by ACS.